Abbott, The Abbott Fund and Direct Relief International reach key HIV testing milestone
27 June 2012 | By Abbott
20 million tests provided over 10 years & more than 150,000 HIV cases prevented...
List view / Grid view
Abbott Laboratories is an American worldwide healthcare company. With headquarters in Lake Bluff, Illinois, it has 94,000 employees and operates in more than 150 countries.
The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; it eventually grew to also sell research-based drugs, medical devices, diagnostics, and nutritional products. It split off the research-based pharmaceuticals into Abbvie in 2013. In 2015, revenues were $20.4 billion.
Abbott has a broad range of branded generic pharmaceuticals, medical devices, diagnostics, and nutrition products. The company’s in-vitro diagnostics business performs immunoassays and blood screening. Its medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other indicators of health. In 1985, the company developed the first HIV blood-screening test.
27 June 2012 | By Abbott
20 million tests provided over 10 years & more than 150,000 HIV cases prevented...
25 June 2012 | By Abbott
Abbott announced that the CHMP has issued a positive opinion for HUMIRA®...
18 June 2012 | By Abbott
Results from five abstracts announced...
6 June 2012 | By Abbott
First Phase 3 study to evaluate an anti-TNF in patients with non-radiographic axial spondyloarthritis...
6 June 2012 | By Abbott
Abbott announced results from two long-term, open-label studies...
5 June 2012 | By Abbott
Abbott have announced the initiation of a pivotal Phase 3 clinical trial...
5 June 2012 | By Abbott
One in three adults doesn’t obtain all of the daily nutrients they need to support optimal health...
29 May 2012 | By Abbott
Latest investigational research findings on HUMIRA®...
15 May 2012 | By Abbott
New indication supported by data from more than 10,000 patients...
3 May 2012 | By Abbott
Abbott plans to establish its first nutrition R&D center with Syngene...
20 April 2012 | By Abbott
Abbott has received U.S. FDA clearance to use its iFS Advanced Femtosecond Laser...
17 April 2012 | By Abbott
Detection of gene abnormalities may help men determine the best approach to treatment...
17 April 2012 | By Abbott
Statistically significant improvements...
11 April 2012 | By
The European Commission has approved HUMIRA®...
9 April 2012 | By Abbott
Abbott announced it has received approval from the Japanese MHLW...